
News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series

Podcast: PBM Problems (Part 3): Monopoly Power in Prescription Drug Markets with Luke Slindee, PharmD
We all know the cost of prescription drugs in the U.S. is a problem. How did we get here and what can we do about it?
From the podcast MTVA Unscripted: Empowering the Move to Value Based Healthcare

CVS hellth: Corporate consolidation is ruining pharmacies and hurting patients
An opinion piece by pharmacist and independent pharmacy advocate Luke Slindee.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.